Clinical Trials Logo

Clinical Trial Summary

Post-operative bleeding in total knee arthroplasty (TKA) can result in hypovolemic shock and unnecessity for allogenic blood transfusions. Intravenous and topical tranexamic acid (TXA) have been well established in reducing blood loss postoperatively. However, there are lack of data on peri-articular TXA injection during TKA. Therefore, the investigators conducted a three-arm prospective, randomized, controlled trial to compare the effectiveness of bleeding reduction of peri-articular TXA injections, intraarticular TXA injections and control group.


Clinical Trial Description

Patients scheduled for unilateral primary TKA; 108 patients were randomly assigned to receive peri-articular TXA, intraarticular TXA and control group. 36 patients received either: (I) 15 mg/kg peri-articular TXA combined with multimodal local anesthetic infiltration (bupivacaine, morphine, ketorolac and epinephrine) into the anterior soft tissue, medial gutter area, lateral gutter area prior to capsular closure and tourniquet deflation (group 1). (II) 2 g of intraarticular TXA after complete capsular closure just before tourniquet deflation (group 2). (III) Don't receive any route of TXA in control group (group 3). Hemoglobin (Hb) concentrations were measured at 24 and 48 hour, and the number of blood transfusions and knee circumference measurements were recorded. Serum TXA was recorded at 2 and 24 hours after operation. The reviewers were blinded to treatment group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03074994
Study type Interventional
Source Thammasat University
Contact Piya Pinsornsak, MD
Email pinpiya2003@yahoo.com
Status Recruiting
Phase Phase 2
Start date October 2016
Completion date September 2019

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02784041 - Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty N/A
Completed NCT02966613 - Fully Disposable Patient-Specific Instrumentation N/A
Completed NCT00137410 - Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee Phase 3
Recruiting NCT03360500 - Cryotherapy Associated With Exercise in Pain Control and Physical Function in Individuals With Knee Osteoarthritis N/A
Completed NCT02967874 - Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment Phase 1/Phase 2
Completed NCT01899417 - Costs and Benefits of ConforMIS iTotal® Knee Replacement System Versus Standard Total Knee
Completed NCT02967744 - NSAID Treatment of Patients With Osteoarthritis N/A
Completed NCT01042093 - Efficacy of Multimodal Perioperative Analgesia With Periarticular Drug Injection in Total Knee Arthroplasty(TKA) N/A
Completed NCT03033238 - Multicenter Bone and Joint Health Study
Completed NCT03011112 - Can 3D Kinematic Parameters Assess the Symptomatic and Functional Severity of KOA? N/A
Completed NCT02975154 - Microcurrent Therapy in the Treatment of Osteoarthritis of the Knee N/A
Completed NCT03684850 - Knee Brace and Biomechanical Footwear in the Treatment of Knee Osteoarthritis. N/A
Completed NCT03007576 - Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem) Phase 1